Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2016

Open Access 01-12-2016 | Research

Early diabetes screening in women with previous gestational diabetes: a new insight

Authors: Aline Nabuco, Samara Pimentel, Carolina A. Cabizuca, Melanie Rodacki, Denise Finamore, Marcus M. Oliveira, Lenita Zajdenverg

Published in: Diabetology & Metabolic Syndrome | Issue 1/2016

Login to get access

Abstract

Background

Gestational diabetes mellitus (GDM) is a risk factor for the development of diabetes mellitus (DM). However, there is a low return rate for this screening, so it is important to search for earlier methods for evaluation after delivery, to increase the number of pregnant women screened, so you can start the treatment or prevention of these early comorbidities. To determine the accuracy of the 75 g 2-h oral glucose tolerance test (OGTT) performed between 48–72 h after delivery for the diagnosis of DM using the OGTT after 6 weeks as the gold standard criterion, and to identify the optimal cutoff points for this exam for diabetes screening after a pregnancy complicated by GDM.

Methods

82 women with previous GDM underwent an OGTT between 48–72 h postpartum and repeated the test 6 weeks after delivery.

Results

The prevalence of DM and prediabetes based on the first OGTT was 3.7 and 32.9 %, respectively, and 8.5 and 20.7 %, respectively, at the second OGTT. For those with DM, the area under the curve (AUC) based on the fasting plasma glucose (FPG) was 0.77 (95 % CI 0.61–0.92), and based on 2-h OGTT was 0.82 (95 % CI 0.66–0.97). For patients with prediabetes, the AUC based on the FPG was 0.73 (95 % CI 0.59–0.86) and based on the 2-h OGTT was 0.74 (95 % CI 0.61–0.87). Using a FPG cutoff value of 78 mg/dl (4.3 mmol/L) and a 2-h OGTT cutoff value of 130 mg/dl (7.2 mmol/L) for DM, the specificity was 58.7 and 60 %, the sensitivity was 71.4 and 85.7 %, the positive predictive value was 13.9 and 16.7 and the negative predictive value was 95.7 and 97.9 %, respectively.

Conclusions

OGTT performed early in postpartum is a useful tool for identifying women with previous GDM who must perform an OGTT 6 weeks after delivery.
Literature
2.
go back to reference Caprio S. Development of type 2 diabetes mellitus in the obese adolescent: a growing challenge. Endocr Pract. 2012;18:791–5.CrossRefPubMed Caprio S. Development of type 2 diabetes mellitus in the obese adolescent: a growing challenge. Endocr Pract. 2012;18:791–5.CrossRefPubMed
3.
go back to reference Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 2007;30(Suppl 2):S141–6.CrossRefPubMed Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 2007;30(Suppl 2):S141–6.CrossRefPubMed
4.
go back to reference Reichelt AJ, Spichler ER, Branchtein L. Fasting plasma glucose is a useful test for the gestational diabetes. Diabetes Care. 1998;21:1246–9.CrossRefPubMed Reichelt AJ, Spichler ER, Branchtein L. Fasting plasma glucose is a useful test for the gestational diabetes. Diabetes Care. 1998;21:1246–9.CrossRefPubMed
5.
go back to reference Bowes SB, Hennessy TR, Umpleby AM. Measurement of glucose metabolism and insulin secretion during normal pregnancy and pregnancy complicated by gestational diabetes. Diabetologia. 1996;39:976–83.CrossRefPubMed Bowes SB, Hennessy TR, Umpleby AM. Measurement of glucose metabolism and insulin secretion during normal pregnancy and pregnancy complicated by gestational diabetes. Diabetologia. 1996;39:976–83.CrossRefPubMed
6.
go back to reference O’Sullivan JB, Mahan CM, Charles D, Dandrow RV. Screening criteria for high-risk gestational diabetic patients. Am J Obstetr Gynecol. 1973;116:895–900. O’Sullivan JB, Mahan CM, Charles D, Dandrow RV. Screening criteria for high-risk gestational diabetic patients. Am J Obstetr Gynecol. 1973;116:895–900.
7.
go back to reference American Diabetes Association. clinical practice recommendations 1996. Diabetes Care. 1996;19(Suppl 1):S1–118. American Diabetes Association. clinical practice recommendations 1996. Diabetes Care. 1996;19(Suppl 1):S1–118.
8.
go back to reference Philipson EH, Super DM. Gestational diabetes mellitus: does it recur in subsequent pregnancy? Am J Obstet Gynecol. 1989;160:1324–31.CrossRefPubMed Philipson EH, Super DM. Gestational diabetes mellitus: does it recur in subsequent pregnancy? Am J Obstet Gynecol. 1989;160:1324–31.CrossRefPubMed
9.
go back to reference Gaudier FL, Hauth JC, Poist M, Corbett DL, Cliver SP. Recurrence of gestational diabetes mellitus. Obstet Gynecol. 1992;80:755–8.PubMed Gaudier FL, Hauth JC, Poist M, Corbett DL, Cliver SP. Recurrence of gestational diabetes mellitus. Obstet Gynecol. 1992;80:755–8.PubMed
10.
go back to reference Coelingh Bennink HJT. Recurrence of gestational diabetes. Eur J Obstet Gynecol Reprod Biol. 1977;7:359–63.CrossRef Coelingh Bennink HJT. Recurrence of gestational diabetes. Eur J Obstet Gynecol Reprod Biol. 1977;7:359–63.CrossRef
11.
go back to reference Grant PT, Oats JN, Beischer NA. The long-term follow-up of women with gestational diabetes. Aust N Z J Obstet Gynaecol. 1986;26:17–22.CrossRefPubMed Grant PT, Oats JN, Beischer NA. The long-term follow-up of women with gestational diabetes. Aust N Z J Obstet Gynaecol. 1986;26:17–22.CrossRefPubMed
12.
go back to reference Moses RG. The recurrence rate of gestational diabetes in subsequent pregnancies. Diabetes Care. 1996;19:1348–50.CrossRefPubMed Moses RG. The recurrence rate of gestational diabetes in subsequent pregnancies. Diabetes Care. 1996;19:1348–50.CrossRefPubMed
13.
go back to reference Damm P. Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Dan Med Bull. 1998;45:495–509.PubMed Damm P. Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Dan Med Bull. 1998;45:495–509.PubMed
14.
15.
go back to reference Tovar A, Chasan-Taber L, Eggleston E, Oken E. Postpartum screening for diabetes among women with a history of gestational diabetes mellitus. Prev Chronic Dis. 2011;8:A124.PubMedPubMedCentral Tovar A, Chasan-Taber L, Eggleston E, Oken E. Postpartum screening for diabetes among women with a history of gestational diabetes mellitus. Prev Chronic Dis. 2011;8:A124.PubMedPubMedCentral
16.
go back to reference Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;14:393–403. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;14:393–403.
17.
go back to reference American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30(Suppl 1):S42–7.CrossRef American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30(Suppl 1):S42–7.CrossRef
18.
go back to reference Metzger BE, Buchanan TA, Coustan DR, de Leia A, Dunger DB. Summary and recommendations of the Fifth International Workshop Conference on gestational diabetes mellitus. Diabetes Care. 2007;2(30 Suppl 2):S251–60.CrossRef Metzger BE, Buchanan TA, Coustan DR, de Leia A, Dunger DB. Summary and recommendations of the Fifth International Workshop Conference on gestational diabetes mellitus. Diabetes Care. 2007;2(30 Suppl 2):S251–60.CrossRef
19.
go back to reference The Diabetes Control and Complications Trial/Epidemiology of Diabetes. Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381–9.CrossRef The Diabetes Control and Complications Trial/Epidemiology of Diabetes. Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381–9.CrossRef
20.
go back to reference Ratner R. Prevention of type 2 diabetes in women with previous gestational diabetes. Diabetes Care. 2007;30:S242–5.CrossRefPubMed Ratner R. Prevention of type 2 diabetes in women with previous gestational diabetes. Diabetes Care. 2007;30:S242–5.CrossRefPubMed
22.
go back to reference UK Prospective Diabetes Study Group. Intensive blood-glucose control with suphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS33). Lancet. 1998;352:837–53.CrossRef UK Prospective Diabetes Study Group. Intensive blood-glucose control with suphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS33). Lancet. 1998;352:837–53.CrossRef
23.
go back to reference The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53.CrossRef The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53.CrossRef
24.
go back to reference American Diabetes Association. Gestational diabetes mellitus (position statement). Diabetes Care. 2004;21(Suppl 1):S88–90. American Diabetes Association. Gestational diabetes mellitus (position statement). Diabetes Care. 2004;21(Suppl 1):S88–90.
25.
go back to reference The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183.CrossRef The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183.CrossRef
26.
go back to reference World Health Organisation. Definition, diagnosis and classification of diabetes and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO; 1999. World Health Organisation. Definition, diagnosis and classification of diabetes and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO; 1999.
28.
go back to reference Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. Can Med Assoc J. 1998;159(Suppl):S1–29. Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. Can Med Assoc J. 1998;159(Suppl):S1–29.
29.
30.
31.
go back to reference Clark HD, Graham ID, Karovitch A, Keely EJ. Do postal reminders increase postpartum screening of Diabetes mellitus in women with gestational diabetes mellitus? (a randomized controlled trial). Am J Obstet Gynecol. 2009;200:634 (e1–7).PubMed Clark HD, Graham ID, Karovitch A, Keely EJ. Do postal reminders increase postpartum screening of Diabetes mellitus in women with gestational diabetes mellitus? (a randomized controlled trial). Am J Obstet Gynecol. 2009;200:634 (e1–7).PubMed
32.
go back to reference Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768–73.CrossRefPubMed Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768–73.CrossRefPubMed
33.
go back to reference Metzger BE, Gabbe SG, Persson B, et al. International Association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–82.CrossRefPubMed Metzger BE, Gabbe SG, Persson B, et al. International Association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–82.CrossRefPubMed
34.
go back to reference World Health Organisation Expert Committee on Diabetes Mellitus. Diabetes mellitus. Geneva: World Health Organisation; 1985. World Health Organisation Expert Committee on Diabetes Mellitus. Diabetes mellitus. Geneva: World Health Organisation; 1985.
35.
go back to reference World Health Organisation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Geneva: WHO; 2006. World Health Organisation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Geneva: WHO; 2006.
37.
go back to reference Xiang A, Kjos S, Takayanagi M, Trigo E, Buchanan T. Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus. Diabetes. 2010;59:2625–30.CrossRefPubMedPubMedCentral Xiang A, Kjos S, Takayanagi M, Trigo E, Buchanan T. Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus. Diabetes. 2010;59:2625–30.CrossRefPubMedPubMedCentral
38.
go back to reference Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab. 2000;13:343–56.CrossRefPubMed Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab. 2000;13:343–56.CrossRefPubMed
39.
go back to reference McIntyre H, Chang A, Callway L, Cowley D, Dyer A, Radaelli T, et al. Hormonal and metabolic factors associated with variations in insulin sensitivity in normal pregnancy. Diabetes Care. 2010;33:356–60.CrossRefPubMed McIntyre H, Chang A, Callway L, Cowley D, Dyer A, Radaelli T, et al. Hormonal and metabolic factors associated with variations in insulin sensitivity in normal pregnancy. Diabetes Care. 2010;33:356–60.CrossRefPubMed
40.
go back to reference Barbour LA. New concepts in insulin resistance of pregnancy and gestational diabetes: long-term implications for mother and offspring. J Obstet Gynaecol. 2003;23:545–9.CrossRefPubMed Barbour LA. New concepts in insulin resistance of pregnancy and gestational diabetes: long-term implications for mother and offspring. J Obstet Gynaecol. 2003;23:545–9.CrossRefPubMed
41.
go back to reference Carr DB, Gabbe S. Gestational diabetes: detection, management and implications. Clin Diabetes. 1998;16:4–11. Carr DB, Gabbe S. Gestational diabetes: detection, management and implications. Clin Diabetes. 1998;16:4–11.
42.
go back to reference Jovanovic-Peterson L, Peterson CM. Review of gestational diabetes and low-calorie diet and physical exercise as therapy. Diabetes Metab Rev. 1996;122:287–308.CrossRef Jovanovic-Peterson L, Peterson CM. Review of gestational diabetes and low-calorie diet and physical exercise as therapy. Diabetes Metab Rev. 1996;122:287–308.CrossRef
43.
go back to reference Metsman JH. Insulin resistance syndrome and gestational diabetes. Endocr Pract. 2003;9(Suppl 2):90–2. Metsman JH. Insulin resistance syndrome and gestational diabetes. Endocr Pract. 2003;9(Suppl 2):90–2.
44.
go back to reference Godo G, Morvay J, Sas M. Hormonal situation on parturition, early puerperium, and lactation (author’s transl). Zentralbl Gynakol. 1979;101(24):1553–61.PubMed Godo G, Morvay J, Sas M. Hormonal situation on parturition, early puerperium, and lactation (author’s transl). Zentralbl Gynakol. 1979;101(24):1553–61.PubMed
45.
go back to reference Mastorakos G, Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci. 2003;997:136–49.CrossRefPubMed Mastorakos G, Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci. 2003;997:136–49.CrossRefPubMed
47.
go back to reference Gupta Y, Gupta A. Post-partum screening after gestational diabetes. Lancet Diabetes Endocrinol. 2013;1:90–1.CrossRefPubMed Gupta Y, Gupta A. Post-partum screening after gestational diabetes. Lancet Diabetes Endocrinol. 2013;1:90–1.CrossRefPubMed
48.
go back to reference McBride CM, Emmons KM, Lipikus IM. Understanding the potential of teachable moments: the case of smoke cessation. Health Educ Res. 2003;18:156–70.CrossRefPubMed McBride CM, Emmons KM, Lipikus IM. Understanding the potential of teachable moments: the case of smoke cessation. Health Educ Res. 2003;18:156–70.CrossRefPubMed
49.
go back to reference Silverman RA, Thakker U, Ellman T, Wong I, Smith K, Ito K, Graff K. Hemoglobin A1c as a screen for previously undiagnosed prediabetes and diabetes in acute-care setting. Diabetes Care. 2011;34:1908–12.CrossRefPubMedPubMedCentral Silverman RA, Thakker U, Ellman T, Wong I, Smith K, Ito K, Graff K. Hemoglobin A1c as a screen for previously undiagnosed prediabetes and diabetes in acute-care setting. Diabetes Care. 2011;34:1908–12.CrossRefPubMedPubMedCentral
50.
go back to reference Gorin AA, Phelan S, Hill JO, Wing RR. Medical triggers are associated with better short- and long- term weight loss outcomes. Prev Med. 2004;39:612–6.CrossRefPubMed Gorin AA, Phelan S, Hill JO, Wing RR. Medical triggers are associated with better short- and long- term weight loss outcomes. Prev Med. 2004;39:612–6.CrossRefPubMed
51.
go back to reference Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862–8.CrossRefPubMed Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862–8.CrossRefPubMed
52.
go back to reference Romero Gutiérrez G, Macias Rocha AL, Puente Alvarez EI. Prevalence of postpartum impaired glucose tolerance after gestational diabetes. Ginecol Obstet Mex. 2012;80(10):631–6.PubMed Romero Gutiérrez G, Macias Rocha AL, Puente Alvarez EI. Prevalence of postpartum impaired glucose tolerance after gestational diabetes. Ginecol Obstet Mex. 2012;80(10):631–6.PubMed
53.
go back to reference Anderberg E, Landin-Olsson M, Kalén J, Frid A, Ursing D, Berntorp K. Prevalence of impaired glucose tolerance and diabetes after gestational diabetes mellitus comparing different cut-off criteria for abnormal glucose tolerance during pregnancy. Acta Obstet Gynecol Scand. 2011;90(11):1252–8. doi:10.1111/j.1600-0412.2011.01214.x (Epub Aug 29 2011).CrossRefPubMed Anderberg E, Landin-Olsson M, Kalén J, Frid A, Ursing D, Berntorp K. Prevalence of impaired glucose tolerance and diabetes after gestational diabetes mellitus comparing different cut-off criteria for abnormal glucose tolerance during pregnancy. Acta Obstet Gynecol Scand. 2011;90(11):1252–8. doi:10.​1111/​j.​1600-0412.​2011.​01214.​x (Epub Aug 29 2011).CrossRefPubMed
54.
go back to reference Ikenoue S, Miyakoshi K, Saisho Y, et al. Clinical impact of women with gestational diabetes mellitus by the new consensus criteria: two-year experience in a single institution in Japan. Endocr J. 2014;61:353–8.CrossRefPubMed Ikenoue S, Miyakoshi K, Saisho Y, et al. Clinical impact of women with gestational diabetes mellitus by the new consensus criteria: two-year experience in a single institution in Japan. Endocr J. 2014;61:353–8.CrossRefPubMed
Metadata
Title
Early diabetes screening in women with previous gestational diabetes: a new insight
Authors
Aline Nabuco
Samara Pimentel
Carolina A. Cabizuca
Melanie Rodacki
Denise Finamore
Marcus M. Oliveira
Lenita Zajdenverg
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2016
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-016-0172-2

Other articles of this Issue 1/2016

Diabetology & Metabolic Syndrome 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.